VFINX
Price
$703.53
Change
+$0.92 (+0.13%)
Updated
Jun 2 closing price
Net Assets
1.6T
VNSCX
Price
$21.07
Change
+$0.05 (+0.24%)
Updated
Jun 2 closing price
Net Assets
579.24M
Interact to see
Advertisement

VFINX vs VNSCX

Header iconVFINX vs VNSCX Comparison
Open Charts VFINX vs VNSCXBanner chart's image
VFINX vs VNSCX Comparison Chart in %
View a ticker or compare two or three
VS
VFINX vs. VNSCX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VFINX is a Buy and VNSCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VFINX has more cash in the bank: 1.6T vs. VNSCX (579M). VFINX pays higher dividends than VNSCX: VFINX (0.93) vs VNSCX (0.00). VFINX was incepted earlier than VNSCX: VFINX (50 years) vs VNSCX (14 years). VNSCX (1.84) is less costly to investors than VFINX (0.14). VNSCX is a more actively managed with annual turnover of: 64.00 vs. VFINX (2.00). VFINX has a lower initial minimum investment than VNSCX: VFINX (0) vs VNSCX (2500). VFINX annual gain was more profitable for investors over the last year : 28.07 vs. VNSCX (10.81). VFINX return over 5 years is better than : 81.37 vs. VNSCX (0.43).
VFINXVNSCXVFINX / VNSCX
Total Expense Ratio0.141.848%
Annual Report Gross Expense Ratio0.141.848%
Fund Existence50 years14 years-
Gain YTD11.1928.295135%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets1.6T579M276,339%
Annual Yield % from dividends0.930.00-
Returns for 1 year28.0710.81260%
Returns for 3 years77.5728.33274%
Returns for 5 years81.370.4318,923%
Returns for 10 years262.1347.82548%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ASYS21.901.25
+6.03%
Amtech Systems
TTI10.890.53
+5.12%
TETRA Technologies
RIO111.672.71
+2.49%
Rio Tinto plc
ROAD111.43-3.31
-2.88%
Construction Partners
ALGS5.17-0.18
-3.36%
Aligos Therapeutics Inc